Comparing the efficacy of aprepitant and ondansetron for the prevention of postoperative nausea and vomiting (PONV): A double blinded, randomised control trial in patients undergoing breast and thyroid surgeries

BACKGROUND AND AIMS: Aprepitant, a Neurokinin-1 receptor antagonist, has been evaluated in abdominal and neurosurgeries, but its effect is less clear in breast and thyroid surgeries, which are also known to be high risk for post-operative nausea and vomiting (PONV). This study was done to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyabalan, Salome, Thampi, Suma Mary, Karuppusami, Reka, Samuel, Kunder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460978/
https://www.ncbi.nlm.nih.gov/pubmed/31000893
http://dx.doi.org/10.4103/ija.IJA_724_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460978/
https://www.ncbi.nlm.nih.gov/pubmed/31000893
http://dx.doi.org/10.4103/ija.IJA_724_18

Ejemplares similares